Millipore Sigma Vibrant Logo

426100 Lactacystin, Synthetic - CAS 1258004-00-0 - Calbiochem

View This Product on Sigma-Aldrich
426100
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
1258004-00-0C₁₅H₂₄N₂O₇S

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
426100-1MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 1 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      426100-200UGCN
      在庫状況検索中…
      現在国内在庫なし
現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル 200 μg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          426100-400UGCN
          在庫状況検索中…
          現在国内在庫なし
現在国内在庫なし
          現在国内在庫有り 
          販売中止
          在庫僅少
          現在国内在庫あり
            Remaining : Will advise
              Remaining : Will advise
              注文対象外
              お問合せください
              Contact Customer Service

              樹脂アンプル 400 μg
              価格を検索中…
              価格が見つかりません
              Minimum Quantity needs to be mulitiple of
              Maximum Quantity is
              弊社照会 詳細を表示 
              値引
              ()
               
              弊社照会
              Description
              OverviewAn irreversible proteasome inhibitor. A Streptomyces metabolite that acts as a highly specific inhibitor of the 20S proteasome (MCP; multicatalytic proteinase complex) (IC50 = 500 nM for 20S proteasome). Blocks proteasome activity by targeting the catalytic β-subunit. Acts as a covalent inhibitor of the chymotrypsin- and trypsin-like activities of the proteasome. Induces neurite outgrowth in Neuro 2A mouse neuroblastoma cells and inhibits progression of synchronized Neuro 2A cells and MG-63 human osteosarcoma cells beyond the G1 phase of the cell cycle. Reported to induce apoptosis in human monoblast U937 cells. Also inhibits NF-κB activation (IC50 = 10 µM).
              Catalogue Number426100
              Brand Family Calbiochem®
              SynonymsProteasome Inhibitor VI
              References
              ReferencesKeyomarsi, K., et al. 2011. Cell. Biol. Toxicol. 27, 123.
              Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
              Dick, L.R., et al. 1996. J. Biol. Chem. 271, 7273.
              Oda, K., et al. 1996. Biochem. Biophys. Res. Commun. 219, 800.
              Fenteany, G., et al. 1995. Science 268, 726.
              Imajoh-Ohmi, S., et al. 1995. Biochem. Biophys. Res. Commun. 217, 1070.
              Jensen, T.J., et al. 1995. Cell 83, 129.
              Katagiri, M.M., et al. 1995. J. Antibiot. 48, 344.
              Mori, S., et al. 1995. J. Biol. Chem. 270, 29447.
              Tanaka, H., et al. 1995. Biochem. Biophys. Res. Commun. 216, 291.
              Fenteany, G., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 3358.
              Omura, S., et al. 1991. J. Antibiot. 44, 117.
              Product Information
              CAS number1258004-00-0
              ATP CompetitiveN
              FormWhite solid
              Hill FormulaC₁₅H₂₄N₂O₇S
              Chemical formulaC₁₅H₂₄N₂O₇S
              ReversibleN
              Structure formula ImageStructure formula Image
              Quality LevelMQ100
              Applications
              Biological Information
              Primary Target20S proteasome (MCP; multicatalytic proteinase complex)
              Primary Target IC<sub>50</sub>500 nM against 20S proteasome; 10 µM against NF-κB activation
              Purity≥99% by HPLC
              Physicochemical Information
              Cell permeableN
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Toxicity Standard Handling
              Storage -20°C
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution in DMSO, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 1 month at -20°C. Unstable in aqueous solutions; reconstitute in H₂O just prior to use.
              Packaging Information
              Transport Information
              Supplemental Information
              Specifications
              Global Trade Item Number
              カタログ番号 GTIN
              426100-1MGCN 04055977187311
              426100-200UGCN 04055977187328
              426100-400UGCN 04055977187335

              Documentation

              Lactacystin, Synthetic - CAS 1258004-00-0 - Calbiochem (M)SDS

              タイトル

              英語版製品安全データシート((M)SDS) 

              Lactacystin, Synthetic - CAS 1258004-00-0 - Calbiochem 試験成績書(CoA)

              タイトルロット番号
              426100

              参考資料

              参考資料の概要
              Keyomarsi, K., et al. 2011. Cell. Biol. Toxicol. 27, 123.
              Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
              Dick, L.R., et al. 1996. J. Biol. Chem. 271, 7273.
              Oda, K., et al. 1996. Biochem. Biophys. Res. Commun. 219, 800.
              Fenteany, G., et al. 1995. Science 268, 726.
              Imajoh-Ohmi, S., et al. 1995. Biochem. Biophys. Res. Commun. 217, 1070.
              Jensen, T.J., et al. 1995. Cell 83, 129.
              Katagiri, M.M., et al. 1995. J. Antibiot. 48, 344.
              Mori, S., et al. 1995. J. Biol. Chem. 270, 29447.
              Tanaka, H., et al. 1995. Biochem. Biophys. Res. Commun. 216, 291.
              Fenteany, G., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 3358.
              Omura, S., et al. 1991. J. Antibiot. 44, 117.

              カタログ

              タイトル
              Caspases and other Apoptosis Related Tools Brochure
              Proteasomes Technical Bulletin

              引用

              Title
            • Keyomarsi, K., et al. 2011. Cell. Biol. Toxicol. 27, 123.
            • Lacher, M.D., et al. 2006. Cancer Research 66, 1648.
            • Wu, C-J., et al. 2005. European Molecular Biology Organization Journal 24, 1886.
            • データシート

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision23-October-2012 JSW
              SynonymsProteasome Inhibitor VI
              DescriptionAn irreversible proteasome inhibitor. A Streptomyces metabolite that acts as a highly specific inhibitor of the 20S proteasome (MCP; multicatalytic proteinase complex) (IC50 = 500 nM for 20S proteasome). Blocks proteasome activity by targeting the catalytic β-subunit. Acts as a covalent inhibitor of the chymotrypsin and trypsin-like activities of the proteasome. Induces neurite outgrowth in Neuro 2A mouse neuroblastoma cells beyond theG1 phase of the cell cycle. Reported to induce apoptosis in human monoblast U937 cells. Also inhibits NF-κB activation (IC50 = 10 µM)
              FormWhite solid
              CAS number1258004-00-0
              Chemical formulaC₁₅H₂₄N₂O₇S
              Structure formulaStructure formula
              Purity≥99% by HPLC
              SolubilityDMSO (50 mg/ml) or H₂O
              Storage -20°C
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution in DMSO, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 1 month at -20°C. Unstable in aqueous solutions; reconstitute in H₂O just prior to use.
              Toxicity Standard Handling
              ReferencesKeyomarsi, K., et al. 2011. Cell. Biol. Toxicol. 27, 123.
              Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
              Dick, L.R., et al. 1996. J. Biol. Chem. 271, 7273.
              Oda, K., et al. 1996. Biochem. Biophys. Res. Commun. 219, 800.
              Fenteany, G., et al. 1995. Science 268, 726.
              Imajoh-Ohmi, S., et al. 1995. Biochem. Biophys. Res. Commun. 217, 1070.
              Jensen, T.J., et al. 1995. Cell 83, 129.
              Katagiri, M.M., et al. 1995. J. Antibiot. 48, 344.
              Mori, S., et al. 1995. J. Biol. Chem. 270, 29447.
              Tanaka, H., et al. 1995. Biochem. Biophys. Res. Commun. 216, 291.
              Fenteany, G., et al. 1994. Proc. Natl. Acad. Sci. USA 91, 3358.
              Omura, S., et al. 1991. J. Antibiot. 44, 117.
              Citation
            • Keyomarsi, K., et al. 2011. Cell. Biol. Toxicol. 27, 123.
            • Lacher, M.D., et al. 2006. Cancer Research 66, 1648.
            • Wu, C-J., et al. 2005. European Molecular Biology Organization Journal 24, 1886.